Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,252 | 1,844 | 1,304 | 538 | N/A |
| Marketable Securities | 32 | 32 | 32 | 31 | N/A |
| Receivables | 56 | 42 | 36 | 35 | N/A |
| TOTAL | $1,526 | $2,244 | $1,626 | $678 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 2 | 2 | 1 | N/A |
| Intangibles | 36 | 42 | 48 | 52 | 0 |
| TOTAL | $36 | $44 | $49 | $53 | $N/A |
| Total Assets | $1,563 | $2,288 | $1,675 | $731 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,101 | 550 | 201 | 587 | 0 |
| Accrued Expenses | 162 | 362 | 291 | N/A | N/A |
| Other current liabilities | N/A | 485 | N/A | N/A | N/A |
| TOTAL | $1,263 | $1,396 | $492 | $679 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,263 | $1,396 | $492 | $679 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 36,951 | 34,890 | 28,906 | 24,704 | N/A |
| Retained earnings | -49,425 | -44,893 | -37,044 | -31,720 | N/A |
| Other shareholders' equity | 6,690 | 4,731 | 3,203 | 1,119 | 0 |
| TOTAL | $300 | $892 | $1,183 | $52 | $N/A |
| Total Liabilities And Equity | $1,563 | $2,288 | $1,675 | $731 | $0 |